Neurocrine Biosciences Reports First-Quarter 2026 Financial Results

Go back to Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) Delayed: 155.01 +2.08 (1.36%)
Previous Close $152.93    52 Week High $58.46 
Open $153.13    52 Week Low $31.25 
Day High $155.27    P/E N/A 
Day Low $152.65    EPS $-0.69 
Volume 515,969